Drug Search Results
More Filters [+]

Lurtotecan

Alternative Names: lurtotecan
Latest Update: 2020-04-09
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: Camptothecin Analogue,TOP Stabilizer

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Astellas Pharma
Company Location: NEW YORK NY 10005
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Lurtotecan

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Peritoneal Cancer|Ovarian Cancer|Small Cell Lung Cancer|Fallopian Tube Cancer|Squamous Cell Carcinoma|Head and Neck Cancer

Phase 1: Oncology Solid Tumor Unspecified

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

I138

P2

Completed

Peritoneal Cancer|Fallopian Tube Cancer|Ovarian Cancer

2002-10-22

EORTC-16008

P2

Completed

Squamous Cell Carcinoma|Head and Neck Cancer

2002-08-01

I123

P1

Completed

Oncology Solid Tumor Unspecified

2001-06-08

NCT00046787

P2

Completed

Small Cell Lung Cancer

None

Recent News Events

Date

Type

Title